Cutting collaborations will not put “America first” – This commentary in Nature by a Syrian pulmonologist whose 2001 Fogarty funded research advanced understanding of a health-impacting trend in his country and in the United States, highlights the cross border benefits of the Center’s international scientific collaborations more directly and succinctly than anything I’ve read so far. […]
Scientific Drought, Golden Eggs, and Global Leadership – Why Trump’s NIH Funding Cuts Would Be a Disaster – This New England Journal of Medicine Perspective piece unpacks the most significant cut ever proposed by a U.S. president to the National Institutes of Health, and the impacts it would have on American leadership in science, the […]
From slowing HIV treatment access, to an immediate $1.2 billion cut in biomedical research funding, to eliminating a program providing income for older Americans, Trump proposal to slash domestic and overseas aid spending this year is deemed unlikely to be accepted, but further highlights administration priorities The U.S. President’s Emergency Plan for AIDS Relief would […]
“We’re not here because tuberculosis is like the common cold and makes you feel bad, we’re here because TB kills people” Washington, DC – From a six-year-old girl who came home to the U.S. sick after a visit to her grandparents in India, and from a long-distance runner from Peru, an audience on Capitol Hill […]
A few days after the White House released an outline of budget priorities, that included a nearly 20 percent cut to medical research funding, and elimination of the global health study supporting Fogarty International Center, four physician scientists who have dedicated their careers to fighting HIV and tuberculosis came to Capitol Hill to talk about […]
Profile: NIH’s Fogarty International Center – A couple of years ago, this article in The Lancet described the widening scope and increasing impact of the U.S. National Institutes of Health Fogarty International Center, since it began to support medical training and research in 1968. “This concept of investing in training outstanding young investigators, both U.S. and […]
With a document short on detail, but sweeping in its proposals to reduce resources for longstanding programs, the President Trump releases “A Budget Blueprint to Make America Great Again“ In a “skinny” budget proposal with vast implications for medical research and public health at home and abroad the Trump administration today outlined a plan of government spending […]
USAID’s celebration of International Women’s Day Wednesday included the release of a statement noting that when women and girls “are empowered to make decisions related to their health, infant deaths decline, nutrition improves, agricultural productivity rises, population growth slows, economies expand and cycles of poverty are broken.” By then, however, the agency’s Standard Provisions for […]
From the handful of people — 50,000 — across Africa with access to life-saving treatment for HIV in 2003, to more than 18 million today, the chronology of U.S. leadership against the pandemic that was filling graveyards, orphaning infants, and decimating the continent’s most productive population, when President George W. Bush signed the legislation creating […]
Open letter to the WHO to put #TBontheList – “WHO: When you make a mistake, fix it,” former CDC head Dr. Tom Frieden tweeted last week, after TB research and response advocates reacted to the World Health Organization’s omission of tuberculosis from its a list of “priority pathogens” demanding urgent research and development efforts. Now […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages […]